Home LiteratureArticle Details
PMID: 1763066 Published · ppublish English Journal Article

Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles.

Steinhauer DA, Wharton SA, Skehel JJ, Wiley DC, Hay AJ

Abstract

Mutants of influenza Rostock virus (H7N1 subtype) were selected for resistance to amantadine hydrochloride at concentrations of the antiviral drug known to affect the function of the virus M2 transmembrane protein. Sequence analysis revealed that three mutants had no changes in M2 but contained a lysine to isoleucine substitution in the hemagglutinin (HA) membrane glycoprotein at position 58 of HA2. The mutant viruses were found to fuse membranes at a pH value 0.7 lower than wild type and to exhibit changes in the conformation of their HAs specifically at the lower pH. The homologous lysine to isoleucine substitution was introduced by site-specific mutagenesis into the HA of X-31 influenza virus (H3 subtype), which was expressed by using vaccinia virus recombinants. The expressed HA also mediated membrane fusion and changed in conformation at a pH value 0.7 lower than wild type. These results indicate that increased acid stability of the HA obviates the consequences of the inhibition of M2 function by amantadine and provide further evidence for the role of M2 in regulating the pH of vesicles involved in glycoprotein transport to the cell surface.

MeSH Terms
Amantadine/pharmacology Animals Blotting, Western Cell Line Drug Resistance, Microbial Enzyme-Linked Immunosorbent Assay Hemagglutinin Glycoproteins, Influenza Virus Hemagglutinins, Viral/genetics,metabolism Hydrogen-Ion Concentration Influenza A virus/drug effects,genetics,physiology Membrane Fusion Models, Molecular Mutagenesis, Site-Directed Protein Conformation Vaccinia virus/genetics Viral Envelope Proteins/genetics
Chemicals
Hemagglutinin Glycoproteins, Influenza Virus Hemagglutinins, Viral Viral Envelope Proteins Amantadine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Steinhauer D A
National Institute for Medical Research, Mill Hill, London, United Kingdom.
Wharton S A
Skehel J J
Wiley D C
Hay A J
References (32)
32 references, click to expand
  1. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.
    Cell. 1991 Oct 4;67(1):117-30 PMID: 1913813
  2. Crystalline antigen from the influenza virus envelope.
    Nat New Biol. 1972 Aug 2;238(83):145-7 PMID: 4626449
  3. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel.
    Virology. 1991 Feb;180(2):617-24 PMID: 1989386
  4. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses.
    Virology. 1991 Jun;182(2):475-85 PMID: 2024485
  5. The specific inhibition of influenza A virus maturation by amantadine: an electron microscopic examination.
    J Gen Virol. 1991 Jan;72 ( Pt 1):191-4 PMID: 1990063
  6. Specific structural alteration of the influenza haemagglutinin by amantadine.
    EMBO J. 1990 Nov;9(11):3469-76 PMID: 2209554
  7. Molecular characterization of a new hemagglutinin, subtype H14, of influenza A virus.
    Virology. 1990 Dec;179(2):759-67 PMID: 2238469
  8. Studies of influenza haemagglutinin-mediated membrane fusion.
    Virology. 1986 Feb;149(1):27-35 PMID: 3946080
  9. Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change.
    J Biol Chem. 1985 Mar 10;260(5):2973-81 PMID: 3972812
  10. A poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells.
    Proc Natl Acad Sci U S A. 1988 Dec;85(24):9431-5 PMID: 2849105
  11. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.
    N Engl J Med. 1989 Dec 21;321(25):1696-702 PMID: 2687687
  12. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.
    Annu Rev Biochem. 1987;56:365-94 PMID: 3304138
  13. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection.
    J Virol. 1988 May;62(5):1508-12 PMID: 3282079
  14. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.
    J Virol. 1988 Aug;62(8):2762-72 PMID: 2455818
  15. The molecular basis of the specific anti-influenza action of amantadine.
    EMBO J. 1985 Nov;4(11):3021-4 PMID: 4065098
  16. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface.
    Cell. 1985 Mar;40(3):627-33 PMID: 3882238
  17. Fusion mutants of the influenza virus hemagglutinin glycoprotein.
    Cell. 1985 Feb;40(2):431-9 PMID: 3967299
  18. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin.
    J Cell Biol. 1987 Dec;105(6 Pt 2):2887-96 PMID: 2447101
  19. Virus entry into animal cells.
    Adv Virus Res. 1989;36:107-51 PMID: 2500008
  20. Protein-mediated membrane fusion.
    Annu Rev Biophys Biophys Chem. 1989;18:187-211 PMID: 2660823
  21. Rapid and efficient site-specific mutagenesis without phenotypic selection.
    Methods Enzymol. 1987;154:367-82 PMID: 3323813
  22. Refinement of the influenza virus hemagglutinin by simulated annealing.
    J Mol Biol. 1990 Apr 20;212(4):737-61 PMID: 2329580
  23. The structure of a membrane fusion mutant of the influenza virus haemagglutinin.
    EMBO J. 1990 Jan;9(1):17-24 PMID: 2295311
  24. Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo- and paramyxoviruses.
    Virology. 1990 May;176(1):274-9 PMID: 2158693
  25. Viral and cellular membrane fusion proteins.
    Annu Rev Physiol. 1990;52:675-97 PMID: 2184772
  26. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.
    J Virol. 1984 Mar;49(3):857-64 PMID: 6321770
  27. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.
    Nature. 1981 Jan 29;289(5796):366-73 PMID: 7464906
  28. Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine.
    J Gen Virol. 1982 May;60(Pt 1):61-6 PMID: 7097251
  29. Influenza virus uncoating in infected cells and effect of rimantadine.
    J Gen Virol. 1982 May;60(Pt 1):49-59 PMID: 7097250
  30. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion.
    Proc Natl Acad Sci U S A. 1982 Feb;79(4):968-72 PMID: 6951181
  31. Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene.
    Cell. 1981 Sep;25(3):805-13 PMID: 7285118
  32. Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties.
    Virology. 1991 Sep;184(1):445-8 PMID: 1871979
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1991-12-15
Pages
11525-9
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC53168
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com